Burong, Ramser O.

HRN: 17-96-16  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
CEFTRIAXONE 1G (VIAL)
01/17/2023
01/24/2023
IV
1g
Q24h
T/c Sepsis
Waiting Final Action 
01/17/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/17/2023
01/24/2023
IV
150mg
Q24h
T/c Sepsis
Waiting Final Action 
01/18/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/18/2023
01/25/2023
IVTT
100mg
Q8
Amoebiasis
Waiting Final Action 
01/20/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/20/2023
01/27/2023
PO
5ml
TID
Amoeba
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: